WELCURE DRUGS & PHARMACEUTICALS LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 13/11/2024 ,inter alia, to consider and approve Unaudited Financial Results of the Company for the 2nd quarter and half year ended on 30th September, 2024